We present the application of single-slice high-resolution FID-MRSI with short acquisition delay at 7T that provides whole-slice metabolite maps in eight patients with different types of glioma. With six minutes measurement time, it could be easily integrated into a standard imaging protocol. The results show that it is possible to resolve metabolic deviations in an extended number of biochemical compounds in tumors with unprecedented spatial details, thereby offering deeper insight into the neurochemical profiles of different glioma types. This suggests that the demonstrated method has a high potential for the research of glioma.
This abstract and the presentation materials are available to members only; a login is required.